Liability concerns in contraceptive research and development

International Journal of Gynecology and Obstetrics

Volumn 67, Issue SUPPL. 2, 1999, Pages

  Segal, S J ^a  

^a POPULATION COUNCIL   (United States)

Author keywords

Contraceptive research; Product liability; US and European tort law

Indexed keywords

BIOMEDICAL AND DENTAL MATERIALS; CONJUGATED ESTROGEN; CONTRACEPTIVE AGENT; DIETHYLSTILBESTROL; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; SPERMICIDAL AGENT; THALIDOMIDE;

COMMERCIAL PHENOMENA; CONFERENCE PAPER; CONTRACEPTION; COST; DECISION MAKING; DRUG DEVELOPMENT; EMOTION; HUMAN; INSURANCE; LAW SUIT; LEGAL LIABILITY; MARKETING; PREGNANCY; PRIORITY JOURNAL; RESEARCH;

EID: 0032754735     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(99)00157-5     Document Type: Conference Paper

References (19)

1. UN Dept of Economic and Social Information Policy and Analysis. Population Division, World Population Prospects, The 1997 Revision: 107.
2. Segal S. Contraceptive development and better family planning. Bull NY Acad Med. 73:1996;92-95.
3. Harlop S, Kost K, Forrest JD. Preventing pregnancies, protecting health: a new look at birth control choices in the United States. Alan Guttmacher Institute, New York, 1991:30-31.
4. Johansson E.D.B. Comparison of the availability of contraceptive methods in selected European countries and the United States. NYU Rev L Soc Change. 23:1998;471-476.
5. Jones E.F., Forrest J.D. Contraceptive failure rates based on the 1988 national survey of family growth. Fam Plann Perspect. 24:1992;12-14.
6. Forrest J.D. Epidemiology of unintended pregnancy and contraceptive use. Am J Obstet Gynecol. 170:1994;1485-1488.
7. Johansson E.D.B. Epidemiology of unintended pregnancy and contraceptive use. Am J Obstet Gynecol. 170:1998;1485-1488.
8. Law S.A. Tort liability and the availability of contraceptive drugs and devices in the United States. NYU Rev L Soc Change. 23:1998;339-401.
9. Mildred M. Litigation rules and culture: the European perspective. NYU Rev L Soc Change. 23:1998;433-442.
10. Mildred M. Litigation rules and culture: the European perspective. NYU Rev L Soc Change. 23:1998;433-442.
11. Christian C.D. Maternal deaths associated with an intrauterine device. Am J Obstet Gynecol. 119:1974;119-126.
12. Law S.A. Maternal deaths associated with an intrauterine device. Am J Obstet Gynecol. 119:1998;119-126.
13. Asbell B. The pill: a biography of the drug that changed the world. 1995;Simon & Schuster, Inc, New York.
14. Law S.A. The pill: a biography of the drug that changed the world. 1998;Simon & Schuster, Inc, New York.
15. Ditzen LS. How a promising contraceptive fell victim to lawsuits. Philadelphia Inquirer, 30 December 1998.
16. Ditzen LS. How a promising contraceptive fell victim to lawsuits. Philadelphia Inquirer, 30 December 1998.
17. Borreson S. Norplant maker had no duty to warn patients of side effects. American Lawyer Media: The legal intelligencer, 9 February 1999.
18. Ditzen LS. Norplant maker had no duty to warn patients of side effects. American Lawyer Media: The legal intelligencer, 1998.
19. Trueland J. Women's action ends as legal aid cancelled. The Scotsman, 9 February 1999.